Purchases and Sales Made in Q4 2023 in Eiger Bio Pharmaceuticals, Inc. (EIGR)
This table provides information about the institutional ownership of Eiger Bio Pharmaceuticals, Inc. (EIGR) during Q4 2023. The information is specifically focused on institutions that hold shares of Eiger BioPharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Propel Bio Management, LLC
Los Angeles, CA |
BUY
|
- |
4.39MNew |
$922K - $1.89M
|
4.39M
$7.6M
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
344KNew |
$72.3K - $148K
|
344K
$595K
|
|
|
Feb 09, 2024
Q4 2023
|
Hrt Financial LP
New York, NY |
BUY
|
- |
29.1KNew |
$6.11K - $12.5K
|
29.1K
$50.4K
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
21.4K+ 59.88% |
$4.5K - $9.22K
|
57.2K
$99K
|
|
|
Feb 14, 2024
Q4 2023
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
14.8K+ 100.31% |
$3.1K - $6.35K
|
29.5K
$51K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
13.8KNew |
$2.9K - $5.94K
|
13.8K
$23.9K
|
|
|
Feb 13, 2024
Q4 2023
|
Prudential Financial Inc
Newark, NJ |
BUY
|
- |
12KNew |
$2.52K - $5.16K
|
12K
$20.8K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
11K+ 19277.19% |
$2.31K - $4.72K
|
11K
$19.1K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
10KNew |
$2.1K - $4.3K
|
10K
$17.3K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
3.82K+ 17.6% |
$802 - $1.64K
|
25.5K
$44.1K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
1.79K+ 10.82% |
$375 - $768
|
18.3K
$31.6K
|
|
|
Feb 02, 2024
Q4 2023
|
Simplex Trading, LLC
|
BUY
|
- |
913+ 7.49% |
$192 - $393
|
13.1K
$22.7K
|
|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
424+ 45.2% |
$89 - $182
|
1.36K
$2.36K
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
166New |
$34.9 - $71.4
|
166
$287
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 09, 2024
Q4 2023
|
Citigroup Inc
|
SELL
|
- |
-793- 21.22% |
$167 - $341
|
2.94K
$5.09K
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-2.3K- 4.55% |
$482 - $987
|
48.1K
$83.2K
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-8.24K- 98.03% |
$1.73K - $3.54K
|
166
$287
|
|
|
Feb 14, 2024
Q4 2023
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-8.3K- 13.28% |
$1.74K - $3.57K
|
54.2K
$93.7K
|
|
|
Feb 12, 2024
Q4 2023
|
Tocqueville Asset Management L.P.
New York, NY |
SELL
|
- |
-13.8K- 26.92% |
$2.89K - $5.91K
|
37.3K
$64.6K
|
|
|
Feb 12, 2024
Q4 2023
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-14.7K- 65.4% |
$3.08K - $6.3K
|
7.75K
$13.4K
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-15.7K- 53.18% |
$3.29K - $6.74K
|
13.8K
$23.9K
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-20K- 98.49% |
$4.2K - $8.59K
|
307
$531
|
|
|
Feb 14, 2024
Q4 2023
|
Rbf Capital, LLC
San Francisco, CA |
SELL
|
- |
-52.5K- 13.43% |
$11K - $22.6K
|
339K
$586K
|
|
|
Feb 13, 2024
Q4 2023
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-63.9K- 26.86% |
$13.4K - $27.5K
|
174K
$301K
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-144K- 7.31% |
$30.1K - $61.7K
|
1.82M
$3.15M
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-229K- 73.81% |
$48K - $98.3K
|
81.1K
$140K
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-302K- 34.13% |
$63.5K - $130K
|
584K
$1.01M
|
|
|
Feb 14, 2024
Q4 2023
|
683 Capital Management, LLC
New York, NY |
SELL
|
- |
-550K- 20.75% |
$116K - $237K
|
2.1M
$3.63M
|
|
|
Feb 14, 2024
Q4 2023
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-1.09M- 12.65% |
$228K - $467K
|
7.51M
$13M
|